enGene Holdings Inc. (NASDAQ: ENGN) Stock Information | RedChip

enGene Holdings Inc. (NASDAQ: ENGN) Listen to this Section

$5.75
-0.1500 ( -2.54% ) 10.9K

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Market Data

Open

$5.75

Previous close

$5.90

Volume

10.9K

Market cap

$268.97M

Day range

$5.48 - $6.13

52 week range

$5.10 - $43.00

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings

Form Type Description Pages Date
3 Insider transactions 1 Nov 13, 2023
8-k 8K-related 17 Nov 09, 2023
3 Insider transactions 1 Nov 07, 2023
4 Insider transactions 1 Nov 02, 2023
4 Insider transactions 1 Nov 02, 2023
4 Insider transactions 1 Nov 02, 2023
4 Insider transactions 1 Nov 02, 2023
4 Insider transactions 1 Nov 02, 2023
4 Insider transactions 1 Nov 02, 2023
4 Insider transactions 1 Nov 02, 2023

Latest News

Terms and Agreement

Please agree to the terms to continue using the chat feature.

About US

Services

Stay Connected